Abogen Biosciences

Private

#mRNA Therapeutics #Infectious Disease #Oncology #Autoimmune Disease

Clinical-stage RNA therapeutics company developing mRNA medicines — prophylactic vaccines and cancer and autoimmune disease therapies — on its proprietary lipid-nanoparticle delivery platform.

Company Info

Sector:Biotechnology

Headquarters:Suzhou, Jiangsu, China

Founded:2019

Website:www.abogenbio.com/

Clinical Development Pipeline

ARCoV

Target: SARS-CoV-2 RBD mRNA

COVID-19 (prophylactic vaccine)

Preclinical

Phase 1

Phase 2

Phase 3

Approved

In vivo mRNA-encoded T cell engager

Target: mRNA-encoded T cell engager

Autoimmune disease

Preclinical

Phase 1

Phase 2

Phase 3

Approved

mRNA cancer immunotherapy program

Target: Tumor-associated antigens

Solid tumors

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Recent News

No recent news updates available for this company.

Leadership Team

Bo Ying

Founder, Chairman & Chief Executive Officer

Careers & Job Openings

See all open roles

All

Suzhou, Jiangsu, China

Apply Now →